Earnings Feed
Start Free
Home/Filings/4/0001062993-22-012388
4//SEC Filing

Van Strydonck, Gerald E. 4

Accession 0001062993-22-012388

CIK 0001205922other
View on SEC.govCompany Profile

Filed

May 12, 8:00 PM ET

Accepted

May 13, 4:43 PM ET

Size

17.3 KB

Accession

0001062993-22-012388

Insider Transaction Report

Form 4
Period: 2022-05-12
VACCINEX, INC.VCNX
Van Strydonck, Gerald E.
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-12+53,254→ 53,254 total
    Exercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $7.17Exp: 2029-09-27→ Common Stock (1,856 underlying)
    1,856

  • Common Stock

    20,000

  • Stock Option (Right to Buy)

    Exercise: $14.90Exp: 2023-03-06→ Common Stock (7,500 underlying)
    7,500

  • Stock Option (Right to Buy)

    Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying)
    6,396

  • Stock Option (Right to Buy)

    Exercise: $7.78From: 2020-05-15→ Common Stock (7,718 underlying)
    7,718

  • Stock Option (Right to Buy)

    Exercise: $5.26Exp: 2029-03-30→ Common Stock (2,501 underlying)
    2,501

  • Stock Option (Right to Buy)

    Exercise: $5.52Exp: 2029-06-29→ Common Stock (2,385 underlying)
    2,385

  • Stock Option (Right to Buy)

    Exercise: $4.85Exp: 2029-12-28→ Common Stock (2,737 underlying)
    2,737

  • Stock Option (Right to Buy)

    Exercise: $3.95From: 2021-05-14→ Common Stock (15,679 underlying)
    15,679

  • Stock Option (Right to Buy)

    Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
    28,586
Footnotes (5)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F3]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  • [F4]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
  • [F5]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.

Documents

1 file

Issuer

VACCINEX, INC.

CIK 0001205922

→
Entity typeother

Related Parties

1
  • filerCIK 0001748247

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:43 PM ET
Size
17.3 KB
View on SEC.gov